MYSTERIOUS: 52 | Mind Blowing Facts

Breakout Momentum Plays You May Not Know About

Momentum investing is all about timing—these three under-the-radar stocks have begun to rise by still seem to have room for further growth.

MarketBeat · Jun 6, 2025

Can Birth Control Give You Brain Tumors? These 400 Women Say The Pfizer Shot Did

Hundreds of women allege Pfizer's contraceptive injection caused tumors, accusing the company of ignoring known dangers and insufficient safety warnings.

International Business Times UK · Jun 6, 2025

23andMe back on the auction block after former CEO makes 11th-hour bid

Anne Wojcicki, ex-CEO of the DNA testing firm, put in a $305m bid, upending Regeneron’s $256m agreement

The Guardian - US · Jun 5, 2025

New ‘superbug’ antibiotic to treat sepsis and pneumonia enters last phase of testing

It is hoped that the drug zosurabalpin will be approved by the end of the decade

The Independent UK · May 27, 2025

Harris urges US against tariff hikes on pharma and microchip sectors

The Irish deputy premier has written to US Secretary for Commerce Howard Lutnick on two sectors that are key to Ireland’s economy.

Evening Standard · May 25, 2025

Pfizer's 7.5% Dividend: Income Haven or House of Cards?

Pfizer's high dividend yield warrants scrutiny regarding its sustainability, given changing revenues and pipeline investments.

MarketBeat · May 23, 2025

Analysts Think These Stocks Could More Than Double in Value

Septerna, Intellia, and Novavax have garnered investor attention for their significant upside potential, but investors should beware the risks as well.

MarketBeat · May 23, 2025

NHS rolls out ‘Amazon-style’ app for prescriptions to free up pharmacies

High street pharmacies including Boots have already adopted the technology

The Independent UK · May 22, 2025

23andMe Sells DNA Database to Regeneron in £256m Deal: Is Your Data Safe?

23andMe's sale to Regeneron transfers genetic data for drug development, raising privacy issues and concerns over consumer control and benefits.

International Business Times UK · May 22, 2025

Company decides not to rebuild chlorine plant with history of fires, explosions and toxic clouds

The company that operated a Georgia chlorine plant with a history of explosions and chemical fires that created toxic clouds has decided not to rebuild its Conyers manufacturing plant

The Independent UK · May 19, 2025